TY - JOUR
T1 - Cost–utility analysis of a palliative care program in Colombia
AU - Rodríguez-Campos, Luisa
AU - Rodriguez-Lesmes, Paul Andres
AU - Cancino, Analhi Palomino
AU - Díaz, Iris del Valle
AU - Gamboa, Luis Fernando
AU - Niuman, Andrea Castillo
AU - Salas, Juan Sebastián
AU - Sarmiento, Gabriela
AU - Martínez-Bernal, Jorge
AU - González-Vélez, Abel E.
PY - 2024/7/6
Y1 - 2024/7/6
N2 - BackgroundThe
economic assessment of health care models in palliative care promotes
their global development. The purpose of the study is to assess the
cost-effectiveness of a palliative care program (named Contigo) with
that of conventional care from the perspective of a health benefit plan
administrator company, Sanitas, in Colombia.MethodsThe
incremental cost-utility ratio (ICUR) and the incremental net monetary
benefit (INMB) were estimated using micro-costing in a retrospective,
analytical cross-sectional study on the care of terminally ill patients
enrolled in a palliative care program. A 6-month time horizon prior to
death was used. The EQ-5D-3 L questionnaire (EQ-5D-3 L) and the McGill
Quality of Life Questionnaire (MQOL) were used to measure the quality of
life.ResultsThe study included 43 patients managed within the
program and 16 patients who received conventional medical management.
The program was less expensive than the conventional practice
(difference of 1,924.35 US dollars (USD), P = 0.18). When compared to
the last 15 days, there is a higher perception of quality of life, which
yielded 0.25 in the EQ-5D-3 L (p < 0.01) and 1.55 in the MQOL
(P < 0.01). The ICUR was negative and the INMB was positive.ConclusionBecause
the Contigo program reduces costs while improving quality of life, it
is considered to be net cost-saving and a model with value in health
care. Greater availability of palliative care programs, such as Contigo,
in Colombia can help reduce existing gaps in access to universal
palliative care health coverage, resulting in more cost-effective care.BackgroundThe
economic assessment of health care models in palliative care promotes
their global development. The purpose of the study is to assess the
cost-effectiveness of a palliative care program (named Contigo) with
that of conventional care from the perspective of a health benefit plan
administrator company, Sanitas, in Colombia.MethodsThe
incremental cost-utility ratio (ICUR) and the incremental net monetary
benefit (INMB) were estimated using micro-costing in a retrospective,
analytical cross-sectional study on the care of terminally ill patients
enrolled in a palliative care program. A 6-month time horizon prior to
death was used. The EQ-5D-3 L questionnaire (EQ-5D-3 L) and the McGill
Quality of Life Questionnaire (MQOL) were used to measure the quality of
life.ResultsThe study included 43 patients managed within the
program and 16 patients who received conventional medical management.
The program was less expensive than the conventional practice
(difference of 1,924.35 US dollars (USD), P = 0.18). When compared to
the last 15 days, there is a higher perception of quality of life, which
yielded 0.25 in the EQ-5D-3 L (p < 0.01) and 1.55 in the MQOL
(P < 0.01). The ICUR was negative and the INMB was positive.ConclusionBecause
the Contigo program reduces costs while improving quality of life, it
is considered to be net cost-saving and a model with value in health
care. Greater availability of palliative care programs, such as Contigo,
in Colombia can help reduce existing gaps in access to universal
palliative care health coverage, resulting in more cost-effective care.BackgroundThe
economic assessment of health care models in palliative care promotes
their global development. The purpose of the study is to assess the
cost-effectiveness of a palliative care program (named Contigo) with
that of conventional care from the perspective of a health benefit plan
administrator company, Sanitas, in Colombia.MethodsThe
incremental cost-utility ratio (ICUR) and the incremental net monetary
benefit (INMB) were estimated using micro-costing in a retrospective,
analytical cross-sectional study on the care of terminally ill patients
enrolled in a palliative care program. A 6-month time horizon prior to
death was used. The EQ-5D-3 L questionnaire (EQ-5D-3 L) and the McGill
Quality of Life Questionnaire (MQOL) were used to measure the quality of
life.ResultsThe study included 43 patients managed within the
program and 16 patients who received conventional medical management.
The program was less expensive than the conventional practice
(difference of 1,924.35 US dollars (USD), P = 0.18). When compared to
the last 15 days, there is a higher perception of quality of life, which
yielded 0.25 in the EQ-5D-3 L (p < 0.01) and 1.55 in the MQOL
(P < 0.01). The ICUR was negative and the INMB was positive.ConclusionBecause
the Contigo program reduces costs while improving quality of life, it
is considered to be net cost-saving and a model with value in health
care. Greater availability of palliative care programs, such as Contigo,
in Colombia can help reduce existing gaps in access to universal
palliative care health coverage, resulting in more cost-effective care.
AB - BackgroundThe
economic assessment of health care models in palliative care promotes
their global development. The purpose of the study is to assess the
cost-effectiveness of a palliative care program (named Contigo) with
that of conventional care from the perspective of a health benefit plan
administrator company, Sanitas, in Colombia.MethodsThe
incremental cost-utility ratio (ICUR) and the incremental net monetary
benefit (INMB) were estimated using micro-costing in a retrospective,
analytical cross-sectional study on the care of terminally ill patients
enrolled in a palliative care program. A 6-month time horizon prior to
death was used. The EQ-5D-3 L questionnaire (EQ-5D-3 L) and the McGill
Quality of Life Questionnaire (MQOL) were used to measure the quality of
life.ResultsThe study included 43 patients managed within the
program and 16 patients who received conventional medical management.
The program was less expensive than the conventional practice
(difference of 1,924.35 US dollars (USD), P = 0.18). When compared to
the last 15 days, there is a higher perception of quality of life, which
yielded 0.25 in the EQ-5D-3 L (p < 0.01) and 1.55 in the MQOL
(P < 0.01). The ICUR was negative and the INMB was positive.ConclusionBecause
the Contigo program reduces costs while improving quality of life, it
is considered to be net cost-saving and a model with value in health
care. Greater availability of palliative care programs, such as Contigo,
in Colombia can help reduce existing gaps in access to universal
palliative care health coverage, resulting in more cost-effective care.BackgroundThe
economic assessment of health care models in palliative care promotes
their global development. The purpose of the study is to assess the
cost-effectiveness of a palliative care program (named Contigo) with
that of conventional care from the perspective of a health benefit plan
administrator company, Sanitas, in Colombia.MethodsThe
incremental cost-utility ratio (ICUR) and the incremental net monetary
benefit (INMB) were estimated using micro-costing in a retrospective,
analytical cross-sectional study on the care of terminally ill patients
enrolled in a palliative care program. A 6-month time horizon prior to
death was used. The EQ-5D-3 L questionnaire (EQ-5D-3 L) and the McGill
Quality of Life Questionnaire (MQOL) were used to measure the quality of
life.ResultsThe study included 43 patients managed within the
program and 16 patients who received conventional medical management.
The program was less expensive than the conventional practice
(difference of 1,924.35 US dollars (USD), P = 0.18). When compared to
the last 15 days, there is a higher perception of quality of life, which
yielded 0.25 in the EQ-5D-3 L (p < 0.01) and 1.55 in the MQOL
(P < 0.01). The ICUR was negative and the INMB was positive.ConclusionBecause
the Contigo program reduces costs while improving quality of life, it
is considered to be net cost-saving and a model with value in health
care. Greater availability of palliative care programs, such as Contigo,
in Colombia can help reduce existing gaps in access to universal
palliative care health coverage, resulting in more cost-effective care.BackgroundThe
economic assessment of health care models in palliative care promotes
their global development. The purpose of the study is to assess the
cost-effectiveness of a palliative care program (named Contigo) with
that of conventional care from the perspective of a health benefit plan
administrator company, Sanitas, in Colombia.MethodsThe
incremental cost-utility ratio (ICUR) and the incremental net monetary
benefit (INMB) were estimated using micro-costing in a retrospective,
analytical cross-sectional study on the care of terminally ill patients
enrolled in a palliative care program. A 6-month time horizon prior to
death was used. The EQ-5D-3 L questionnaire (EQ-5D-3 L) and the McGill
Quality of Life Questionnaire (MQOL) were used to measure the quality of
life.ResultsThe study included 43 patients managed within the
program and 16 patients who received conventional medical management.
The program was less expensive than the conventional practice
(difference of 1,924.35 US dollars (USD), P = 0.18). When compared to
the last 15 days, there is a higher perception of quality of life, which
yielded 0.25 in the EQ-5D-3 L (p < 0.01) and 1.55 in the MQOL
(P < 0.01). The ICUR was negative and the INMB was positive.ConclusionBecause
the Contigo program reduces costs while improving quality of life, it
is considered to be net cost-saving and a model with value in health
care. Greater availability of palliative care programs, such as Contigo,
in Colombia can help reduce existing gaps in access to universal
palliative care health coverage, resulting in more cost-effective care.
UR - http://dx.doi.org/10.1186/s12904-024-01476-6
U2 - 10.1186/s12904-024-01476-6
DO - 10.1186/s12904-024-01476-6
M3 - Research Article
C2 - 38970056
SN - 1472-684X
JO - BMC Palliative Care
JF - BMC Palliative Care
ER -
